OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

Introduction

Fungal diseases are neglected worldwide by public health authorities. GAFFI efforts are directed at:
  • Identifying and publicising gaps in diagnostics and treatments for fungal diseases,
  • Consulting on how services could be improved through facilitating training, encouraging companies to expand their markets and recommending improvements in infrastructure,
  • Estimating the burden of serious fungal diseases, country by country. Over 65 countries with a population >1 million have been addressed, and many are published (view),
  • Develop, implement and evaluate country-wide diagnostic programs. Guatemala (fungal infections in AIDS) is the first (view)
  • Influence national and international agencies to ‘adopt’ fungal diseases alongside existing programs including TB, microbiology, AMR, NTDs and incorporation of key generic antifungals onto the WHO Essential Medicines List.
  • Focussed diagnostic improvements for GAFFI’s priority diseases.
Globally, over 300 million people of all ages suffer from a serious fungal infection every year. Of these over 1.66 million people are estimated to die. Most serious fungal infections are ‘hidden’ because of other health problems. The objective: 95% of patients with serious fungal infections are diagnosed and treated.
Loading Video Player....
Woodrow Maitland Brown tells of his personal experience of having aspergillosis.

“The incidence of cryptococcal meningitis remains high despite record levels of antiretroviral therapy rollout in Boswana. "Cryptococcal meningitis requires a rethink – only 40% of these patients are still alive at 12 months". Dr Joe Jarvis, EMBO Mycoses in AIDS meeting in Cape Town. ”